Glenmark Pharma and Manappuram Finance Among ShortTerm Opportunities Identified by Religare Broking ZVRA Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response QVCGP Q3 2025 Earnings Preferred Stock Reports Significant Loss Amid Ongoing Operational Challenges BHC Q1 2026 Earnings EPS Surges Past Expectations Despite Revenue Uncertainty Mineralys Therapeutics Q1 2026 Earnings Narrowed Loss Per Share as Pipeline Progress Continues Civista Bancshares Q1 2026 Earnings Strong Net Interest Margin Drives EPS Beat Stock Edges Higher